Shots:
Dr. Jay Backstrom in an engaging conversation with PharmaShots, shares the highlights of the P-II Topaz trial designed to evaluate the safety and efficacy of apitegromab for the treatment of Spinal Muscle Atrophy (Type 2 & 3)
With the potential to transform care in SMA by directly addressing progressive muscle weakness, apitegromab aims to…
